These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 80044)

  • 1. [Ways to increase the specific activity of anti-influenzal donor gamma-globulin].
    Malafeeva LK; Bundzen NG; Polianskaia NIu; Goriunova VV
    Tr Inst Im Pastera; 1976; 47():140-6. PubMed ID: 80044
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience in using an absorbed influenza chemical vaccine for the immunization of donors in producing anti-influenzal gamma-globulin].
    Egorov PA; Isupov FG; Tuĭmedova RA; Afanas'eva GA; Lobanova AM
    Tr Inst Im Pastera; 1976; 47():163-6. PubMed ID: 80045
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the therapeutic action of anti-influenza gamma-globulins obtained by donor vaccination with live and killed vaccines].
    Galkina MV; Volkova VA
    Vopr Okhr Materin Det; 1979 Dec; 24(12):16-9. PubMed ID: 93345
    [No Abstract]   [Full Text] [Related]  

  • 4. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis].
    Mukhina LP; Bichurina MA; Rozaeva NR
    Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza].
    Shvartsman IaS; Tsybul'skaia NV; Ispolatova AV
    Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 8. [Course of antibodies in men after vaccination with the inactivated influenca vaccine Alorbat (author's transl)].
    Pressler K; Schenk KD
    Med Klin; 1978 Sep; 73(38):1321-6. PubMed ID: 703655
    [No Abstract]   [Full Text] [Related]  

  • 9. [Homologous and heterologous antibody induction in influenzal infection and immunization].
    Rudenko LG; Rafaél'skaia TI; Nesterenko LS
    Vopr Virusol; 1977; (4):477-80. PubMed ID: 579009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selection of the influenza virus vaccinal strain by means of crossed protection experiments on mice].
    Briantseva EA
    Tr Inst Im Pastera; 1976; 47():19-23. PubMed ID: 1088724
    [No Abstract]   [Full Text] [Related]  

  • 11. [Homologous and heterologous antibody response induced in man by anti-influenza vaccine containing A/England/42/72 and b/Massachusetts/71].
    Galanti B; Picciotto L; Ruggiero G; Romano E; Vaccaro L
    Boll Ist Sieroter Milan; 1976 Mar; 55(71):13-7. PubMed ID: 1021152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1992-93 season.
    Can Commun Dis Rep; 1992 May; 18(10):73-8. PubMed ID: 1284383
    [No Abstract]   [Full Text] [Related]  

  • 13. The immune response to influenza virus. 3. Changes in the avidity and specificity of early IgM and IgG antibodies.
    Webster RG
    Immunology; 1968 Jan; 14(1):39-52. PubMed ID: 4169724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 15. The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
    Khanlou H; Sanchez S; Babaie M; Chien C; Hamwi G; Ricaurte JC; Stein T; Bhatti L; Denouden P; Farthing C
    Arch Intern Med; 2006 Jul; 166(13):1417. PubMed ID: 16832008
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of the reproductive and immunogenic activity of moderately attenuated influenza A/1977-1980 viruses].
    Zhilova GP; Ermolaeva OM; Orlov VA
    Tr Inst Im Pastera; 1982; 58():25-30. PubMed ID: 7187550
    [No Abstract]   [Full Text] [Related]  

  • 17. Existence of the natural antibody against human-gamma-globulin in bovine sera.
    Sagan Z
    Arch Immunol Ther Exp (Warsz); 1981; 29(4):451-4. PubMed ID: 6174102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1994-95 season.
    Can Commun Dis Rep; 1994 Jun; 20(11):85-92. PubMed ID: 7522728
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunity to influenza in older adults with chronic obstructive pulmonary disease.
    Gorse GJ; O'Connor TZ; Newman FK; Mandava MD; Mendelman PM; Wittes J; Peduzzi PN
    J Infect Dis; 2004 Jul; 190(1):11-9. PubMed ID: 15195238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tolerance and immunogenic effect of preventive influenza vaccination in patients with chronic lung diseases].
    Krebs A; Adamczyk B; Brachmann I; Christ R; Klett G; Luther P; Pohl WD; Pohl S; Tischner H
    Z Erkr Atmungsorgane; 1986; 167(1-2):109-15. PubMed ID: 3765704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.